Advances in imaging technologies have demonstrated promise in the early detection of dysplasia and cancer. They have also provided the ability to assess submucosal and vascular structures, helping differentiate neoplastic from non-neoplastic tissue. The aim of this concise casebased review is to discuss how optical imaging can impact patient management decisions during endoscopy, using real-life scenarios.
T he fields of endoscopic imaging and therapeutics have evolved considerably over the last decade. Chromoendoscopy increases the contrast between normal mucosa and neoplasia, either via electronic spectral enhancement or with the use of topical dyes, and has facilitated the evaluation of superficial gastrointestinal neoplasia. 1 Electronic options include narrow-band imaging (NBI, Olympus Corp), iScan (Pentax Corp), and blue light/blue laser imaging (Fujifilm Corp). NBI uses an optical filter that allows passage of blue and green wavelengths but blocks red wavelength from the white light spectrum. 2 Blue-green light is absorbed by hemoglobin, rendering blood vessels darker, while adjacent tissues are brighter. This increases the contrast and thus visibility between reddish (neoplastic/inflamed) tissue and normal tissue, and highlights the vascular/angiogenic features of early neoplasia. Several studies have demonstrated the improved efficacy of NBI in detecting Barrett's esophagus-associated intestinal metaplasia and high-grade dysplasia (HGD), compared with conventional white light endoscopy. 3 Areas with intestinal metaplasia appear to have a flat, villous-type mucosal pattern with branching vessels, whereas HGD appears to have irregular blood vessels with disrupted mucosa. The Barrett's international NBI group proposed and validated an NBI classification system to detect dysplasia and cancer. 4 A regular mucosal pattern is characterized by circular, ridged, villous or tubular mucosal patterns, and regular vascular patterns are characterized by blood vessels located along or between mucosal ridges and/or those showing normal, long branching patterns. In contrast, irregular mucosa, often seen in neoplasia, is characterized by complex surface patterns, and irregular vascular patterns can be recognized by nonuniform branching patterns and diameter of blood vessels. 4 With these criteria, the Barrett's international NBI group was able to identify patients with dysplasia with an 85% overall accuracy, 81% positive predictive value, 85% negative predictive value, and substantial interobserver agreement (kappa value of 0.68). In practice, the main value of NBI and similar technologies is to highlight abnormal areas for targeted biopsy, and when dysplasia is confirmed, to delineate areas to remove by endoscopic mucosal resection (EMR).
NBI has been studied extensively in the management of colon polyps, 5 notably with the clinical application of "virtual histology." Several studies including metaanalyses have assessed the safety and accuracy of optical diagnoses for small polyps (<10 mm). 5 The NBI international colorectal endoscopic classification (NICE) proposed and validated the criteria, which can help differentiate nonneoplastic from neoplastic polyps, including those with deep submucosal invasion, using NBI in vivo (Figure 1) . 6 A meta-analysis of studies of NBI for optical diagnosis of colonic polyp histology reported high diagnostic accuracy with a sensitivity of 91% and specificity of 83%. 7 Up to 30% of colorectal cancers arise along the serrated neoplasia pathway, with the sessile serrated polyp (SSP) recognized as the most relevant precursor lesion. 8 The endoscopic diagnosis of SSP is challenging, but has made progress with the development and validation of the WASP criteria. 9 In this study, the NICE criteria were combined with 4 serrated polyp features (ie, indistinct borders, clouded surface, irregular shape, and dark spots inside the crypt). 9 A polyp classified as NICE 1 or NICE 2 with at least 2 serrated features was considered to be SSP. For high confidence diagnoses, the accuracy of optical diagnosis for SSP versus non-SSP was 0.91 (95% CI, 0.88-0.94) and 0.89 (95% CI, 0.85-0.92) for neoplastic versus hyperplastic. The pooled negative predictive value for diminutive neoplastic lesions diagnosed with high confidence was 0.91 (95% CI, 0.83-0.96).
A limitation of the NICE classification is that it cannot differentiate villous histology or grade of dysplasia in colonic polyps. However, it is very effective in differentiating hyperplastic from adenomatous polyps. In current practice, the main value of NBI and similar technologies is to assist with polypectomy decisions. Small rectosigmoid polyps that are diagnosed as hyperplastic with high confidence can be left behind, avoiding unnecessary resection. Conversely, large, flat polyps should be carefully examined with high definition and NBI (or equivalent) for features of deeply invasive cancers. Noninvasive lesions and superficially invasive lesions can be removed by EMR or submucosal dissection, whereas deeply invasive (into the deep submucosa or below) should be referred for surgery.
The following cases depict how NBI can be used in real-life situations and assist patient care decisions.
Case 1
A 62-year-old white man was referred to our endoscopy center for management of Barrett's esophagus. He underwent esophagogastroduodenoscopy at an outside institution secondary to gastrointestinal bleeding. He was found to have a 10-cm segment of Barrett's mucosa with associated inflammatory changes. Biopsies revealed areas of HGD, as interpreted by 2 outside pathologists.
We performed an esophagogastroduodenoscopy and found esophageal changes consistent with Barrett's esophagus from 30 cm to 40 cm from the incisors. This was classified as C10-M10 per the Prague criteria. Subtle nodular mucosa was noted with NBI at 35 cm to 40 cm in the 9-o'clock to 12-o'clock position (Figure 2 ). Based on the Barrett's international NBI group criteria, no changes consistent with deep invasion were seen. We performed wide field EMR using a band captivator device (Boston Scientific, Marlborough, MA), without complications. Final pathology revealed intestinal metaplasia with lowgrade dysplasia. An important teaching point in this case is to inspect Barrett`s mucosa carefully both with white light and NBI, because mucosal changes can sometimes be subtle. Video 1 shows the use of NBI in real time endoscopy, in identification of the nodular lesion and its resection.
Case 2
A 68-year-old white man with a 6-year history of Barrett's esophagus and radiofrequency ablation for HGD was referred to our endoscopy center for further management of a nodular area consistent with esophageal adenocarcinoma. We advised the patient to undergo surgery, but he opted for endoscopic therapy. A computed tomography/ positron emission tomography scan was performed, and no evidence of metastatic disease was seen.
We decided to proceed with esophagogastroduodenoscopy and endoscopic ultrasound. The patient was found to have Barrett's esophagus from 28 cm to 34 cm, categorized as C0-M6 per the Prague criteria. A nodular area with a depression was noted from 28 cm to 29 cm (Figure 3) . On NBI examination, the mucosa and vascular pattern of the nodular and depressed area were irregular, consistent with HGD. The area adjacent to the HGD had a regular mucosal and vascular pattern. The lesion was noted to be T1-N0 on endoscopic ultrasound.
Based on the NBI images we first resected the area consistent with esophageal adenocarcinoma. Then we performed a wide-field EMR with a band captivator device (Boston Scientific) of the nodular area. To ensure negative margins, we resected the adjacent mucosa in a complete concentric ring ("Rosette" resection) and the tissue was placed in a separate jar and sent for histopathologic analysis. A third "ring" of biopsies from the outermost margin was obtained from nondysplasticappearing Barrett's.
Pathology of the first set of specimens was consistent with esophageal adenocarcinoma with negative deep margins. The specimen in the second jar was esophageal mucosa with Barrett's mucosa with HGD. The third set of biopsies was Barrett's mucosa with no dysplasia (Figure 4 ). There are 2 important teaching points in this case. First, if there is no deep invasion, focal cancerous lesions can be resected endoscopically. Second, when resecting suspected cancerous lesions, it is important to resect a rim of normal tissue to ensure negative margins, and use NBI to guide the wide field resection. (A) Transition of normal squamous esophageal mucosa (green asterisk) to dysplastic glandular epithelium (blue asterisk) that overlies an intramucosal adenocarcinoma that extends to the muscularis mucosa (black asterisk) (hematoxylineosin, original magnification Â10). (B) Higher power image of the transition from normal squamous esophageal mucosa (green asterisk) to dysplastic glandular epithelium (blue asterisk) that overlies an intramucosal adenocarcinoma. The glands in the intramucosal carcinoma range from single lumen (yellow asterisk) crowded multiple-lumen (orange asterisk) structures. The cells lining these neoplastic glands show a loss of apical mucin production, loss of polarity, a high degree of nuclear pleomorphism, and anisonucleosis. Mitotic figures are relatively easy to find (red asterisk) (hematoxylin-eosin, original magnification Â20). (C) Intramucosal adenocarcinoma (blue asterisk) extending to the muscularis mucosa (black asterisk). Underneath the muscularis mucosa is the vascular submucosa and deep margin, which are negative for tumor (black ink) (hematoxylin-eosin, original magnification Â10).
Case 3
A 62-year-old white woman was seen at our endoscopy center for a routine screening colonoscopy. She had small tubular adenomas found and resected during a previous colonoscopy. During cecal retroflexion, we found a 12-mm polyp behind the ileocecal valve ( Figure 5 ). The polyp was classified as NICE 2 and, given its cloudy appearance and dark spots inside the crypts, a diagnosis of SSP was made. The patient underwent EMR with complete en bloc removal of the polyp. The final pathology was consistent with SSP without cytologic dysplasia. Video 2 is representative of how to use NBI in real time endoscopy to identify SSP lesions and how to perform the resection.
Conclusions
Various studies have shown white light endoscopy alone is often not sufficient to make endoscopic diagnoses with high accuracy. 8 When aided with electronic imaging, such as NBI, optical diagnoses can achieve diagnostic accuracy comparable with standard histopathologic assessment. The cases presented here show that electronic chomoendoscopy can be a critical tool for the endoscopist in the diagnosis and management of various lesions. With adequate training and experience, endoscopists should be able to incorporate optical diagnosis tools into practice. 
